Prime Medicine
Julia Heffernan has a diverse work experience spanning different roles and companies. Julia started their career as an Undergraduate Research Assistant at the University of New Hampshire in 2015. After that, they joined Analytical Lab Group as a Microbiologist I in 2017. In 2019, Julia moved back to the University of New Hampshire as a Graduate Researcher. Julia then transitioned to working at Prime Medicine, Inc., first as an Associate Scientist II in 2021, and later as a Senior Associate Scientist starting in July 2022.
Julia Heffernan completed their Bachelor's degree in BMS: Medical Microbiology at the University of New Hampshire from 2013 to 2017. Subsequently, they pursued a Master's degree in Microbiology, General at the University of New Hampshire from 2019 to 2021.
This person is not in any offices
Prime Medicine
4 followers
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.